NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the second quarter were flat year over year, as it experienced a late-quarter slowdown in instrument systems orders.

The company posted Q2 revenues of $451 million, short of the average Wall Street estimate of $466.4 million. It reported a profit of $89.3 million, or $1.03 per share, during the quarter, compared to a profit of $97.7 million, or $1.09 per share, a year ago.

On a non-GAAP basis, Waters had EPS of $1.08, below the average analyst estimate of $1.21.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.